Electroporation-based technologies for medicine: principles, applications, and challenges

ML Yarmush, A Golberg, G Serša… - Annual review of …, 2014 - annualreviews.org
When high-amplitude, short-duration pulsed electric fields are applied to cells and tissues,
the permeability of the cell membranes and tissue is increased. This increase in permeability …

Electroporation delivery of DNA vaccines: prospects for success

NY Sardesai, DB Weiner - Current opinion in immunology, 2011 - Elsevier
A number of noteworthy technology advances in DNA vaccines research and development
over the past few years have led to the resurgence of this field as a viable vaccine modality …

[HTML][HTML] Improvement of different vaccine delivery systems for cancer therapy

A Bolhassani, S Safaiyan, S Rafati - Molecular cancer, 2011 - Springer
Cancer vaccines are the promising tools in the hands of the clinical oncologist. Many tumor-
associated antigens are excellent targets for immune therapy and vaccine design. Optimally …

[HTML][HTML] Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

S Daayana, E Elkord, U Winters, M Pawlita… - British journal of …, 2010 - nature.com
Background: Vulval intraepithelial neoplasia (VIN) is a premalignant condition, which is
frequently associated with type HPV16 infection, and multifocal disease has high rates of …

Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines

SHT Jorritsma, EJ Gowans, B Grubor-Bauk… - Vaccine, 2016 - Elsevier
DNA vaccines are ideal candidates for global vaccination purposes because they are
inexpensive and easy to manufacture on a large scale such that even people living in low …

Physical energy for drug delivery; poration, concentration and activation

S Lakshmanan, GK Gupta, P Avci, R Chandran… - Advanced drug delivery …, 2014 - Elsevier
Techniques for controlling the rate and duration of drug delivery, while targeting specific
locations of the body for treatment, to deliver the cargo (drugs or DNA) to particular parts of …

[HTML][HTML] A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer

RK Anchoori, B Karanam, S Peng, JW Wang, R Jiang… - Cancer cell, 2013 - cell.com
The bis-benzylidine piperidone RA190 covalently binds to cysteine 88 of ubiquitin receptor
RPN13 in the 19S regulatory particle and inhibits proteasome function, triggering rapid …

[HTML][HTML] Vaccination into the dermal compartment: techniques, challenges, and prospects

J Hettinga, R Carlisle - Vaccines, 2020 - mdpi.com
In 2019, an 'influenza pandemic'and 'vaccine hesitancy'were listed as two of the top 10
challenges to global health by the WHO. The skin is a unique vaccination site, due to its …

Current state in the development of candidate therapeutic HPV vaccines

A Yang, J Jeang, K Cheng, T Cheng… - Expert review of …, 2016 - Taylor & Francis
The identification of human papillomavirus (HPV) as an etiological factor for HPV-associated
malignancies creates the opportunity to control these cancers through vaccination …

[HTML][HTML] An updated overview of HPV-associated head and neck carcinomas

A Zaravinos - Oncotarget, 2014 - ncbi.nlm.nih.gov
Human papilloma virus (HPV)-associated head and neck carcinoma is quite heterogeneous
and most of the tumors arise in the oral cavity, oropharynx, hypopharynx and larynx. HPV …